Retatrutide
A triple-receptor agonist (GIP/GLP-1/glucagon) studied for metabolic research. 15 mg lyophilized vial, 2–8 °C storage.
Plain-language overview not yet generated.
What is Retatrutide?
Retatrutide (LY3437943) is a triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors, currently investigated for its role in metabolic regulation research.
Research use only. Not for human or veterinary consumption. This page is for educational and informational purposes only.
Mechanism of action
By simultaneously engaging three distinct receptor pathways, Retatrutide modulates energy homeostasis through complementary mechanisms. Researchers study the additive and synergistic effects across GIP, GLP-1, and glucagon receptor activation.
Presentation
Each vial contains 15 mg of lyophilized Retatrutide powder. Reconstitution requires bacteriostatic water. Use the reconstitution calculator for an educational walkthrough of the math involved.
Storage
Store at 2–8 °C, protected from light. Once reconstituted, use within the timeframe established in your research protocol.
Ready to order Retatrutide?
Orders are handled on WhatsApp. Delivered to your door.